Amphetamine Extended-Release
NDC 62542-025, Amphetamine Extended-Release, tablet, orally disintegrating, from Neos Therapeutics, LP.
- Product NDC
- 62542-025
- Status
- Listed
- Labeler
- Neos Therapeutics, LP
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA204326
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/62542-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMPHETAMINE15.7 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62542-025-30 | 62542002530 | 30 BLISTER PACK in 1 CARTON (62542-025-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| 62542-025-31 | 62542002531 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62542-025-31) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/48d0f55c-f847-4d26-b2ed-94b5a2770228NADAC price for package 62542002530
GET /v1/drugs/nadac/62542002530
Use it
Look up 62542-025 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62542-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62542-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.